Recombinant human interleukin-1A (rhIL-1A) is a potent cytokine with significant roles in inflammatory and immune responses. Due to its diverse biological activities, rhIL-1A has emerged as a viable therapeutic target for a variety of conditions. Characterization of rhIL-1A is crucial for understanding its modes of action and optimizing its efficac